PRECLINICAL ALZHEIMER'S DISEASE
Clinical trials for PRECLINICAL ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new PRECLINICAL ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for PRECLINICAL ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new drug delay Alzheimer's? major trial underway
Disease control OngoingThis study tests whether the drug lecanemab can slow memory loss and reduce brain plaque in people with very early signs of Alzheimer's disease. About 1,400 participants aged 55-80 with elevated brain amyloid (a key Alzheimer's protein) will receive either lecanemab or a placebo …
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 26, 2026 08:15 UTC
-
New vaccine aims to halt Alzheimer's before symptoms start
Disease control OngoingThis study tests an experimental vaccine (JNJ-64042056) designed to help the immune system target and clear a harmful protein called tau in the brain. The goal is to slow or stop the spread of tau, which is linked to Alzheimer's disease. The trial includes 55 people with early si…
Matched conditions: PRECLINICAL ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Janssen Pharmaceutica N.V., Belgium • Aim: Disease control
Last updated May 26, 2026 08:13 UTC